204 related articles for article (PubMed ID: 31415878)
1. A solid lipid nanoparticle formulation of 4-(N)-docosahexaenoyl 2', 2'-difluorodeoxycytidine with increased solubility, stability, and antitumor activity.
Valdes SA; Alzhrani RF; Rodriguez A; Lansakara-P DSP; Thakkar SG; Cui Z
Int J Pharm; 2019 Oct; 570():118609. PubMed ID: 31415878
[TBL] [Abstract][Full Text] [Related]
2. Effect of a Solid Lipid Nanoparticle Formulation on the Bioavailability of 4-(N)-Docosahexaenoyl 2', 2'-Difluorodeoxycytidine After Oral Administration.
Valdes SA; Alzhrani RF; Lansakara-P DSP; Cui Z
AAPS PharmSciTech; 2020 Jan; 21(3):77. PubMed ID: 31970527
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, Characterization, and In Vitro and In Vivo Evaluations of 4-(N)-Docosahexaenoyl 2', 2'-Difluorodeoxycytidine with Potent and Broad-Spectrum Antitumor Activity.
Naguib YW; Lansakara-P D; Lashinger LM; Rodriguez BL; Valdes S; Niu M; Aldayel AM; Peng L; Hursting SD; Cui Z
Neoplasia; 2016 Jan; 18(1):33-48. PubMed ID: 26806350
[TBL] [Abstract][Full Text] [Related]
4. Preparation of intravenous injection nanoformulation of VESylated gemcitabine by co-assembly with TPGS and its anti-tumor activity in pancreatic tumor-bearing mice.
Xu Y; Meng H; Du F; Lu W; Liu S; Huang J; Yu J
Int J Pharm; 2015 Nov; 495(2):792-7. PubMed ID: 26410754
[TBL] [Abstract][Full Text] [Related]
5. Characterization and stability of nanostructured lipid carriers as drug delivery system.
Abbasalipourkabir R; Salehzadeh A; Abdullah R
Pak J Biol Sci; 2012 Feb; 15(3):141-6. PubMed ID: 22866544
[TBL] [Abstract][Full Text] [Related]
6. Enhanced Oral Absorption of All-trans Retinoic Acid upon Encapsulation in Solid Lipid Nanoparticles.
Kumar M; Sharma G; Singla D; Singh S; Kakkar V; Gulati JS; Kaur IP
Pharm Nanotechnol; 2020; 8(6):495-510. PubMed ID: 33115399
[TBL] [Abstract][Full Text] [Related]
7. 4-(N)-Docosahexaenoyl 2', 2'-difluorodeoxycytidine induces immunogenic cell death in colon and pancreatic carcinoma models as a single agent.
Hufnagel S; Xu H; Colemam MF; Valdes SA; Liu KA; Hursting SD; Cui Z
Cancer Chemother Pharmacol; 2022 Jan; 89(1):59-69. PubMed ID: 34698902
[TBL] [Abstract][Full Text] [Related]
8. Improved tumor targeting and antitumor activity of camptothecin loaded solid lipid nanoparticles by preinjection of blank solid lipid nanoparticles.
Jang DJ; Moon C; Oh E
Biomed Pharmacother; 2016 May; 80():162-172. PubMed ID: 27133053
[TBL] [Abstract][Full Text] [Related]
9. Lecithin/TPGS-based spray-dried self-microemulsifying drug delivery systems: In vitro pulmonary deposition and cytotoxicity.
Ishak RA; Osman R
Int J Pharm; 2015 May; 485(1-2):249-60. PubMed ID: 25772421
[TBL] [Abstract][Full Text] [Related]
10. Synergistic inhibition of breast cancer metastasis by silibinin-loaded lipid nanoparticles containing TPGS.
Xu P; Yin Q; Shen J; Chen L; Yu H; Zhang Z; Li Y
Int J Pharm; 2013 Sep; 454(1):21-30. PubMed ID: 23830941
[TBL] [Abstract][Full Text] [Related]
11. Development of Curcumin-Loaded Solid Lipid Nanoparticles Utilizing Glyceryl Monostearate as Single Lipid Using QbD Approach: Characterization and Evaluation of Anticancer Activity Against Human Breast Cancer Cell Line.
Bhatt H; Rompicharla SVK; Komanduri N; Aashma S; Paradkar S; Ghosh B; Biswas S
Curr Drug Deliv; 2018; 15(9):1271-1283. PubMed ID: 29732970
[TBL] [Abstract][Full Text] [Related]
12. Preclinical Evaluation of the Short-Term Toxicity of 4-(N)-Docosahexaenoyl 2´, 2´- Difluorodeoxycytidine (DHA-dFdC).
Valdes S; Naguib YW; Finch RA; Baze WB; Jolly CA; Cui Z
Pharm Res; 2017 Jun; 34(6):1224-1232. PubMed ID: 28352993
[TBL] [Abstract][Full Text] [Related]
13. Vitamin E TPGS Emulsified Vinorelbine Bitartrate Loaded Solid Lipid Nanoparticles (SLN): Formulation Development, Optimization and In vitro Characterization.
Maurya L; Singh S; Rajamanickam VM; Narayan G
Curr Drug Deliv; 2018; 15(8):1135-1145. PubMed ID: 29629662
[TBL] [Abstract][Full Text] [Related]
14. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
[TBL] [Abstract][Full Text] [Related]
15. Enhancing the antitumor activity of berberine hydrochloride by solid lipid nanoparticle encapsulation.
Wang L; Li H; Wang S; Liu R; Wu Z; Wang C; Wang Y; Chen M
AAPS PharmSciTech; 2014 Aug; 15(4):834-44. PubMed ID: 24696391
[TBL] [Abstract][Full Text] [Related]
16. Solid lipid nanoparticles of anticancer drug andrographolide: formulation, in vitro and in vivo studies.
Parveen R; Ahmad FJ; Iqbal Z; Samim M; Ahmad S
Drug Dev Ind Pharm; 2014 Sep; 40(9):1206-12. PubMed ID: 23826860
[TBL] [Abstract][Full Text] [Related]
17. Self-assembled targeted nanoparticles based on transferrin-modified eight-arm-polyethylene glycol-dihydroartemisinin conjugate.
Liu K; Dai L; Li C; Liu J; Wang L; Lei J
Sci Rep; 2016 Jul; 6():29461. PubMed ID: 27377918
[TBL] [Abstract][Full Text] [Related]
18. Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin.
Ji H; Tang J; Li M; Ren J; Zheng N; Wu L
Drug Deliv; 2016; 23(2):459-70. PubMed ID: 24892628
[TBL] [Abstract][Full Text] [Related]
19. Surface-modified solid lipid nanoparticles for oral delivery of docetaxel: enhanced intestinal absorption and lymphatic uptake.
Cho HJ; Park JW; Yoon IS; Kim DD
Int J Nanomedicine; 2014; 9():495-504. PubMed ID: 24531717
[TBL] [Abstract][Full Text] [Related]
20. Antitumor efficiency of D-alpha-tocopheryl polyethylene glycol 1000 succinate-b-poly(epsilon-caprolactone-ran-lactide) nanoparticle-based delivery of docetaxel in mice bearing cervical cancer.
Wang Z; Zeng X; Ma Y; Liu J; Tang X; Gao Y; Liu K; Zhang J; Ming P; Huang L; Mei L
J Biomed Nanotechnol; 2014 Aug; 10(8):1509-19. PubMed ID: 25016651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
